Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes. [electronic resource]
Producer: 20100812Description: 874-81 p. digitalISSN:- 1555-905X
- Aged
- Antibodies -- blood
- Aspirin -- adverse effects
- Atorvastatin
- Cause of Death
- Chi-Square Distribution
- Death, Sudden -- etiology
- Diabetes Mellitus, Type 2 -- complications
- Double-Blind Method
- Female
- Germany
- Heparin -- immunology
- Heptanoic Acids -- therapeutic use
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Kaplan-Meier Estimate
- Kidney Diseases -- complications
- Logistic Models
- Male
- Middle Aged
- Myocardial Infarction -- immunology
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Factor 4 -- immunology
- Proportional Hazards Models
- Prospective Studies
- Pyrroles -- therapeutic use
- Renal Dialysis -- adverse effects
- Risk Assessment
- Risk Factors
- Stroke -- immunology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.